Opportunity ID: 329841

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-21-023
Funding Opportunity Title: Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.273 — Alcohol Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Nov 16, 2020
Last Updated Date: Nov 16, 2020
Original Closing Date for Applications: Nov 15, 2023
Current Closing Date for Applications: Nov 15, 2023
Archive Date: Dec 21, 2023
Estimated Total Program Funding:
Award Ceiling: $225,000
Award Floor:

Eligibility

Eligible Applicants: Independent school districts
County governments
Native American tribal governments (Federally recognized)
For profit organizations other than small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Special district governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Public housing authorities/Indian housing authorities
Public and State controlled institutions of higher education
State governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: As part of the Collaborative Research on Addiction at NIH (CRAN) initiative, NIDA, NIAAA, and NCI join to issue this FOA. The purpose of this FOA is to support the development and testing of interventions, models, and/or frameworks that examine system-level implementation of evidence-based interventions, guidelines, or principles to improve the delivery, uptake, quality, and sustainability of substance use prevention and treatment interventions and services
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-21-023.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Folder 329841 Full Announcement-PAR-21-023 -> PAR-21-023-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or before January 24, 2022 PKG00264132 Jun 19, 2021 Jan 24, 2022 View
FORMS-G Use for due dates on or before January 24, 2023 PKG00272336 Feb 28, 2022 Jan 24, 2023 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00278264 Nov 10, 2022 Nov 15, 2023 View

Package 1

Mandatory forms

329841 RR_SF424_2_0-2.0.pdf

329841 PHS398_CoverPageSupplement_5_0-5.0.pdf

329841 RR_OtherProjectInfo_1_4-1.4.pdf

329841 PerformanceSite_2_0-2.0.pdf

329841 RR_KeyPersonExpanded_2_0-2.0.pdf

329841 PHS398_ResearchPlan_4_0-4.0.pdf

329841 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

329841 RR_Budget_1_4-1.4.pdf

329841 RR_SubawardBudget30_1_4-1.4.pdf

329841 PHS398_ModularBudget_1_2-1.2.pdf

329841 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

329841 RR_SF424_5_0-5.0.pdf

329841 PHS398_CoverPageSupplement_5_0-5.0.pdf

329841 RR_OtherProjectInfo_1_4-1.4.pdf

329841 PerformanceSite_4_0-4.0.pdf

329841 RR_KeyPersonExpanded_4_0-4.0.pdf

329841 PHS398_ResearchPlan_4_0-4.0.pdf

329841 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

329841 RR_Budget_3_0-3.0.pdf

329841 RR_SubawardBudget30_3_0-3.0.pdf

329841 PHS398_ModularBudget_1_2-1.2.pdf

329841 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

329841 RR_SF424_5_0-5.0.pdf

329841 PHS398_CoverPageSupplement_5_0-5.0.pdf

329841 RR_OtherProjectInfo_1_4-1.4.pdf

329841 PerformanceSite_4_0-4.0.pdf

329841 RR_KeyPersonExpanded_4_0-4.0.pdf

329841 PHS398_ResearchPlan_5_0-5.0.pdf

329841 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

329841 RR_Budget_3_0-3.0.pdf

329841 RR_SubawardBudget30_3_0-3.0.pdf

329841 PHS398_ModularBudget_1_2-1.2.pdf

329841 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-10T18:02:55-05:00

Share This Post, Choose Your Platform!

About the Author: